Pharmacologic targeting of bacterial β-glucuronidase alleviates nonsteroidal anti-inflammatory drug-induced enteropathy in mice.
about
Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategiesMolecular Insights into Microbial -Glucuronidase Inhibition to Abrogate CPT-11 ToxicityDeveloping a metagenomic view of xenobiotic metabolismMechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics.Real-time imaging of intestinal bacterial β-glucuronidase activity by hydrolysis of a fluorescent probeHost-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics.Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug ToxicityMicrobial determinants of biochemical individuality and their impact on toxicology and pharmacology.The microbiota, chemical symbiosis, and human disease.Evaluation of the effect of blackcurrant products on gut microbiota and on markers of risk for colon cancer in humans.The human microbiome is a source of therapeutic drug targets.Intestinal microbiome and digoxin inactivation: meal plan for digoxin users?Understanding and modulating mammalian-microbial communication for improved human health.NSAID enteropathy and bacteria: a complicated relationship.Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids.Unique β-Glucuronidase Locus in Gut Microbiomes of Crohn's Disease Patients and Unaffected First-Degree RelativesThe microbial pharmacists within us: a metagenomic view of xenobiotic metabolismThe metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions.Role of intestinal cytochrome p450 enzymes in diclofenac-induced toxicity in the small intestine.Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery.Glucuronides in the gut: Sugar-driven symbioses between microbe and host.Bacterial β-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokineticsMechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.An Atlas of β-Glucuronidases in the Human Intestinal Microbiome.Non-cytochrome P450-mediated bioactivation and its toxicological relevance.Gut microbiome interactions with drug metabolism, efficacy, and toxicity.Rebamipide protects small intestinal mucosal injuries caused by indomethacin by modulating intestinal microbiota and the gene expression in intestinal mucosa in a rat model.Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity.Diclofenac toxicity in human intestine ex vivo is not related to the formation of intestinal metabolites.How close are we to developing enteric-protective drugs against non-steroidal anti-inflammatory drug-induced small intestinal injury? New mechanistic insight from preclinical models.Nonsteroidal Anti-Inflammatory Drug-Induced Leaky Gut Modeled Using Polarized Monolayers of Primary Human Intestinal Epithelial Cells.Non-steroidal anti-inflammatory drug-induced enteropathy.Role of enterohepatic recirculation in drug disposition: cooperation and complications.Structural basis for the regulation of β-glucuronidase expression by human gut Enterobacteriaceae.Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs.The role of gut microbiota in the modulation of drug action: a focus on some clinically significant issues.Immunomodulatory interplay of the microbiome and therapy of rheumatic diseases.Glucuronidation: driving factors and their impact on glucuronide dispositionExperimental study of diclofenac and its biliary metabolites on anastomotic healingβ-Glucuronidases of opportunistic bacteria are the major contributors to xenobiotic-induced toxicity in the gut
P2860
Q27000132-D4C73DFD-AB82-498D-B524-5B501B2538F2Q27678202-A382E2F7-B550-449C-8869-26DA26D88B1CQ28273307-F8BBAF02-2AD5-4B31-B82A-EBAE4CA77180Q33779249-EA08636F-C23B-445A-9E83-BE4E109E9DC3Q33784710-5C95A373-2709-448B-B096-B914488EBFE1Q34311685-70B3DDAB-2DBC-409E-A4A1-56EEBB737A02Q34493889-B69E510D-B0AD-40E6-B512-F15B60420F03Q34615534-8DE2711F-ED49-4CAF-86CE-BCD92AAEAAA8Q34616219-04407B02-2F5E-4F99-81F4-FB75811AB0CBQ34722373-D0118FC9-FB7E-46CC-8FE1-788CAD50C562Q34726528-2936EB6A-13DB-4EB2-9A6D-9DABA402970FQ35012050-B6DBBAAA-3665-41D6-B492-AA77C1F752DEQ35026463-A1D9B78A-CFAD-4FF0-9AED-AB5A99E54BEEQ35540435-71539340-5291-4F4F-B322-9D5A8E355C55Q35742169-F29CBCC2-265E-4285-B281-0EB9716E827DQ35908239-6D3EE293-8690-47CE-A24A-758395884D6EQ35955534-57A602BB-CEFC-435E-8D84-C75E39705F7DQ36038992-6A213833-3A5E-4710-9F2D-BAAD0CA1AAEAQ36335498-4A9EC8EA-23F6-4FBD-9C21-D8114CC1CF08Q36340545-099DB786-6644-43C7-8928-A8CC4EDDFACBQ36340552-9B840822-B2FD-4D7C-B336-7CC705AA4554Q37679135-AD38FC39-246A-48DA-A953-F379FF064493Q38097424-7065AAB6-8F92-42D9-942D-DCE01379BF06Q38746100-3828B19C-8836-495D-81F9-D0AF56C66F04Q38929936-7A7AA20B-72D9-4563-A886-D70C89D54FDEQ38945423-484D12AC-4B8A-47C0-BD7A-D25C7399F705Q41361724-FF6258D0-D09C-4540-93D6-6DD9E7A06F43Q41871344-A4B1F39E-8770-4B8B-A625-6D5D075FEC71Q42705851-28BF35BD-CB00-4EE2-AAFF-1B0EAD2E3996Q43609300-2CB6C447-B6FF-481C-880D-FB470E3CECEDQ44876695-AC38D0F2-07AB-41FF-81A2-CBA4FE9E9DCDQ45400230-4F2C8E8A-15B1-42E3-9490-7D7063C47275Q46578287-AACEE6B3-5AE7-437F-9C9F-67B52F4592ABQ47263968-A06ADDB5-62C4-428C-AE18-5F6F3BABB66DQ48226113-C035631F-095F-44ED-AEAC-D8358397F4AFQ50054146-5B8FBD60-5E62-48D5-BEE1-84B78A4E20D9Q50067815-15BE35B5-C4E5-4EDE-9AE5-3A047523871DQ56030213-BF94BAAE-C7CB-4111-913E-F1EB0D4F4DCFQ57119214-7ED0F9C5-4E75-4004-B54C-A7BF782EF19BQ58608842-C4105DAE-A10B-42AC-82E9-E83BE7C513DB
P2860
Pharmacologic targeting of bacterial β-glucuronidase alleviates nonsteroidal anti-inflammatory drug-induced enteropathy in mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Pharmacologic targeting of bac ...... g-induced enteropathy in mice.
@ast
Pharmacologic targeting of bac ...... g-induced enteropathy in mice.
@en
type
label
Pharmacologic targeting of bac ...... g-induced enteropathy in mice.
@ast
Pharmacologic targeting of bac ...... g-induced enteropathy in mice.
@en
prefLabel
Pharmacologic targeting of bac ...... g-induced enteropathy in mice.
@ast
Pharmacologic targeting of bac ...... g-induced enteropathy in mice.
@en
P2093
P2860
P356
P1476
Pharmacologic targeting of bac ...... g-induced enteropathy in mice.
@en
P2093
Amanda LoGuidice
Bret D Wallace
Lauren Bendel
Urs A Boelsterli
P2860
P304
P356
10.1124/JPET.111.191122
P407
P577
2012-02-10T00:00:00Z